OpenBilldrug price receipt

NADAC week of 2026-10-14

TESTOSTERONE CYP 2,000 MG/10 ML

For 10 mL

Pharmacies pay

$23.11 – $35.82 filed

10 × $2.31081 to $3.58188 per ML (the 10 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$83.28 filed

10 × $8.32789 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.3× – 3.6× estimated

Medicare paid between 2.3× and 3.6× what pharmacies pay, depending on the NDC.

Part D averages every strength and form sold under “Testosterone Cypionate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$31.58 – $46.19 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TESTOSTERONE CYP 2,000 MG/10 ML is how the CMS NADAC file names this product. The FDA NDC Directory lists it as testosterone cypionate.

FDA gives its dosage form as “injection” and “injection, solution” and its route as intramuscular.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Hospira, Inc. and Padagis US LLC.

FDA’s Established Pharmacologic Class for it is Androgen.

The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes); the FDA directory lists 9 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $23.11 – $35.82 for 10 mL, depending on the NDC ($2.31081 to $3.58188 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Hikma Pharmaceuticals USA Inc.2$3.58188 per ML filed
Padagis US LLC2$3.58188 per ML filed
Alvogen Inc.1$2.31081 per ML filed
Eugia US LLC1$3.58188 per ML filed
Hospira, Inc.1$3.58188 per ML filed
Wilshire Pharmaceuticals1$3.58188 per ML filed
Xiromed LLC1$3.58188 per ML filed
Not listed as a package in the FDA directory1$3.58188 per ML filed
All 10 NDCs, with labeler and price
  • 00143-9005-01 · Hikma Pharmaceuticals USA Inc. · $3.58188 per ML · eff. 2026-09-23 filed
  • 00143-9726-01 · Hikma Pharmaceuticals USA Inc. · $3.58188 per ML · eff. 2026-09-23 filed
  • 00409-6562-20 · Hospira, Inc. · $3.58188 per ML · eff. 2026-09-23 filed
  • 00574-0820-10 · Padagis US LLC · $3.58188 per ML · eff. 2026-09-23 filed
  • 00574-0827-10 · Padagis US LLC · $3.58188 per ML · eff. 2026-09-23 filed
  • 47781-0910-22 · not listed as a package in the FDA directory · $3.58188 per ML · eff. 2026-09-23 filed
  • 47781-0910-91 · Alvogen Inc. · $2.31081 per ML · eff. 2026-09-23 filed
  • 52536-0625-10 · Wilshire Pharmaceuticals · $3.58188 per ML · eff. 2026-09-23 filed
  • 55150-0278-01 · Eugia US LLC · $3.58188 per ML · eff. 2026-09-23 filed
  • 70700-0290-22 · Xiromed LLC · $3.58188 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name testosterone cypionate with TESTOSTERONE CYP 2,000 MG/10 ML.

ProductPharmacies pay per unitMedicare per unit
DEPO-TESTOSTERONE 1,000 MG/10 ML
brand · injection, solution
$6.91704 per ML filed
eff. 2025-12-17
$10.09719 per ML filed
Part D 2024 average
TESTOSTERONE CYP 1,000 MG/10 ML
generic · injection, solution / injection
$4.52814 per ML filed
eff. 2026-09-23
$8.32789 per ML filed
Part D 2024 average
TESTOSTERONE CYP 2,000 MG/10 ML this page
generic · injection / injection, solution
$2.31081 to $3.58188 per ML filed
eff. 2026-09-23
$8.32789 per ML filed
Part D 2024 average
TESTOSTERONE CYP 200 MG/ML
generic · injection / injection, solution
$11.3924 per ML filed
eff. 2026-09-23
$8.32789 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 10 NDCs’ NADAC prices is $3.58188 per ML filed.

Of the 8 other products in FDA’s Androgen class priced per ML, 7 have a higher middle NADAC price and 1 a lower one. The one in the middle is TESTOSTERONE CYP 200 MG/ML, at $11.3924 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $83.28 for 10 mL, at an average of $8.32789 per ML in 2024 (2024-01-01 to 2024-12-31) for “Testosterone Cypionate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,118,253 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TESTOSTERONE CYP 2,000 MG/10 ML labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Testosterone Cypionate / Testosterone Cypionate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 10 mL?
NADAC prices this product per ML. In the FDA NDC Directory, NDC 47781-0910-91 (“10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22)”) is a carton of 10 vials, 100 mL in all: a wholesale pack of identical units, so OpenBill counts one vial of it. Its package descriptions of the other 8 NDCs give 10 mL in one package (“1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL”). It does not list one of this product’s NDCs. So the card starts at one vial: 10 ML. Change it to match your prescription.